BiotechTV

•

Kanal • 5 Sendungen

Biowissenschaften

Biowissenschaften

Zweiwöchentlich
Biowissenschaften

Biowissenschaften

5. März
Biowissenschaften

Biowissenschaften

vor 1 Tag
Biowissenschaften

Biowissenschaften

2. Feb.
Biowissenschaften

Biowissenschaften

23. Apr.

11. JAN.

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

11. Jan.

•

1 Std. 15 Min.
26. JAN.

Episode 33: Pappas Capital's Art Pappas

Art Pappas describes his early career, which involved numerous overseas posts for large companies, and how it let him to eventually found Pappas Capital. He discusses the various ways the firm invests, and how having corporates partners as LPs and co-investors has been a recipe for success.

26. Jan.

•

58 Min.
22.09.2025

Episode 25: Atlas Venture's Bruce Booth

Bruce Booth discusses his education and early career, the structure of Atlas and the types of investments it makes, investing in assets vs platforms, and more.

22.09.2025

•

1 Std. 18 Min.
01.12.2025

Episode 29: Averin Managing Partner David Berry

He describes his early life and education, 18 years of company building at Flagship Pioneering, founding Averin (previously called Bedford Bridge) with his brother, and investing at the intersection of healthcare and technology.

01.12.2025

•

1 Std. 19 Min.
9. FEB.

Episode 34: General Atlantic's Brett Zbar

Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.

9. Feb.

•

1 Std. 7 Min.
9. MÄRZ

Episode 36: Sofinnova Invetments' Jim Healy

He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.

9. März

•

1 Std. 2 Min.
18.12.2024

Episode 8: Canaan Partners' Julie Grant

A general partner the firm, she describes her career path, including time spent at Goldman Sachs and Genentech, before landing at Canaan over a decade ago. She discusses the firm's investment approach to healthcare, and boldly moving into new categories of medicine even in cases where an organization doesn't have existing commercial infrastructure.

18.12.2024

•

1 Std. 8 Min.
10.03.2025

Episode 14: Aditum Bio's Joe Jimenez

Joe Jimenez describes the career path in consumer products that led him to pharma, his time running Novartis, and the idea to co-found Aditum Bio with his partner Mark Fishman. He explains Aditum's investment philosophy, and why they like focusing on translational medicine opportunities that are just heading into the clinic. Plus, his thoughts on making R&D more efficient.

10.03.2025

•

1 Std. 13 Min.
07.04.2025

Episode 16: RA Capital's Josh Resnick

Josh Resnick describes his career path, which includes working on the venture side of both private funds and pharma (Merck). He explains the different investment strategies of RA Capital, and talks about how the firm's Raven company building incubator fits in. Plus, his thoughts on venture investing in the current environment.

07.04.2025

•

1 Std. 12 Min.
22.07.2025

Metsera CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA

He describes data that Mestera presented at ADA for its monthly-dosed GLP1 and also its amylin analog. Plus, recent learnings about the field in general, including what orforglipron might mean for the oral therapy space and why Metsera believes in an oral peptide.

22.07.2025

•

18 Min.

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Channel Website

BiotechTV

Top-Sendungen

Episode 32: ARCH Venture Partners' Bob Nelsen

Episode 33: Pappas Capital's Art Pappas

Episode 25: Atlas Venture's Bruce Booth

Episode 29: Averin Managing Partner David Berry

Episode 34: General Atlantic's Brett Zbar

Episode 36: Sofinnova Invetments' Jim Healy

Episode 8: Canaan Partners' Julie Grant

Episode 14: Aditum Bio's Joe Jimenez

Episode 16: RA Capital's Josh Resnick

Metsera CEO Whit Bernard shares an update on the company's obesity programs, and comments on the state of the field post ADA

Info

BiotechTV

Top-Sendungen

Top-Folgen

Info